Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

32.45
Delayed Data
As of Jul 27
 -0.59 / -1.79%
Today’s Change
27.60
Today|||52-Week Range
55.79
-10.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues5.1B5.7B6.5B5.8B
 
 
 
 
 
Cost of Goods Sold1.9B2.2B2.8B2.4B
 
 
 
 
 
Depreciation And Amortization314.0M587.3M331.7M495.2M
 
 
 
 
 
 
Operating ExpensesGross Income2.9B2.9B3.4B2.9B
 
 
 
 
 
General Expenses1.7B1.9B2.1B1.7B
 
 
 
 
 
Research And Development379.9M674.9M683.4M471.4M
 
 
 
 
 
Total Operating Expenses3.8B4.8B5.2B4.6B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.3B903.9M1.3B1.2B
 
 
 
 
 
Extraordinary Credit4.1M29.5M----
 
 
 
Extraordinary Charge-964.4M-810.3M-1.5B-260.0M
 
 
 
 
 
Interest Expense On Debt--178.1M480.6M135.1M
 
 
 
 
Equity In Earnings15.2M2.0M-3.0M7.2M
 
 
 
 
 
Other Expenses-160.1M681.0M-221.8M-86.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income259.3M626.0M-913.2M709.7M
 
 
 
 
 
Income Taxes-29.4M-210.7M-57.0M-55.7M
 
 
 
 
 
Minority Interest-12.2M-2.0M-999.2K-4.1M
 
 
 
 
 
Preferred Dividend-66.9M-65.1M-64.9M-67.1M
 
 
 
 
 
Net Income257.3M419.4M-972.2M665.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS914.0M979.0M1.0B1.0B
 
 
 
 
 
Shares To Calculate EPS Diluted920.0M984.0M1.0B1.0B
 
 
 
 
 
 
Earnings Per ShareEPS$0.21$0.36-$1.11$0.59
 
 
 
 
 
EPS Diluted$0.20$0.36-$1.02$0.59